Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database

Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database

Background: A potential risk of suicide associated with liraglutide or semaglutide treatments has recently emerged. Therefore, we decided to investigate the reporting probability of suicidal events among glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Methods: A retrospective pharmacovigilanc...

Full description

Bibliographic Details
Main Authors: Rosanna Ruggiero, Annamaria Mascolo, Angela Spezzaferri, Claudia Carpentieri, Daniele Torella, Liberata Sportiello, Francesco Rossi, Giuseppe Paolisso, Annalisa Capuano
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Pharmaceuticals
Subjects:
retrospective study
pharmacovigilance
safety
glucagon-like peptide-1 receptor agonists
suicidal event
disproportional reporting
Online Access:https://www.mdpi.com/1424-8247/17/2/147

Internet

https://www.mdpi.com/1424-8247/17/2/147

Similar Items